RESUMEN
Immune responses to both SARS-CoV-2 infection and its associated vaccines have been highly variable within the general population. The increasing evidence of long-lasting symptoms after resolution of infection, called post-acute sequelae of COVID-19 (PASC) or "Long COVID," suggests that immune-mediated mechanisms are at play. Closely related endemic common human coronaviruses (hCoV) can induce pre-existing and potentially cross-reactive immunity, which can then affect primary SARS-CoV-2 infection, as well as vaccination responses. The influence of pre-existing immunity from these hCoVs, as well as responses generated from original CoV2 strains or vaccines on the development of new high-affinity responses to CoV2 antigenic viral variants, needs to be better understood given the need for continuous vaccine adaptation and application in the population. Due in part to thymic involution, normal aging is associated with reduced naïve T cell compartments and impaired primary antigen responsiveness, resulting in a reliance on the pre-existing cross-reactive memory cell pool which may be of lower affinity, restricted in diversity, or of shorter duration. These effects can also be mediated by the presence of down-regulatory anti-idiotype responses which also increase in aging. Given the tremendous heterogeneity of clinical data, utilization of preclinical models offers the greatest ability to assess immune responses under a controlled setting. These models should now involve prior antigen/viral exposure combined with incorporation of modifying factors such as age on immune responses and effects. This will also allow for mechanistic dissection and understanding of the different immune pathways involved in both SARS-CoV-2 pathogen and potential vaccine responses over time and how pre-existing memory responses, including potential anti-idiotype responses, can affect efficacy as well as potential off-target effects in different tissues as well as modeling PASC.
Asunto(s)
COVID-19 , Vacunas , Humanos , Síndrome Post Agudo de COVID-19 , SARS-CoV-2 , Envejecimiento , Idiotipos de InmunoglobulinasAsunto(s)
Humanos , Alergia e Inmunología , Cardiología , Gastroenterología , Medicina Interna , Nefrología , Neumología , Psiquiatría , Enfermedades Transmisibles , GenéticaAsunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto Joven , Adulto , Persona de Mediana Edad , Anciano , Medicina Clínica , Medicina Interna/métodosRESUMEN
The seventeenth edition of Harrisons has a full-color format that draws from and extends the excellent appearance of the sixteenth edition to make the content more accessible and pleasant to read. The placement of color illustrations within the chapters rather than in the separate atlas was very favorably received by our sixteenth edition readers and has been continued in the current edition. Many changes to the design of this edition have been made in order to speed the readers navigation through the textual and visual materials. For example, tables have been shaded for ease of reading, citations in tables and illustrations are now more instantly notable and in color, and our Treatment sections in each chapter have been redesigned to allow even faster access. The new global icons call greater attention to key epidemiologic and clinical differences in the practice of medicine throughout the world. The seventeenth edition has been enriched by the addition of a new editor, Joseph Loscalzo, MD, PhD, who joined with our most senior editor Eugene Braunwald, MD, in contributing to and/or editing of chapters in the Parts on Disorders of the Cardiovascular System, Disorders of the Respiratory System, and Disorders of the Kidney and Urinary Tract. The addition of Dr. Loscalzo provides a smooth editorial transition in preparation for the upcoming retirement from Harrisons of Dr. Braunwald who has served as an esteemed editor for 12 editions